9BIC image
Entry Detail
PDB ID:
9BIC
Keywords:
Title:
N-Me-D-Leu2,D-Thr5-clovibactin
Biological Source:
Source Organism:
PDB Version:
Deposition Date:
2024-04-23
Release Date:
2024-09-18
Method Details:
Experimental Method:
Resolution:
2.05 Å
R-Value Free:
0.20
R-Value Work:
0.15
R-Value Observed:
0.15
Space Group:
P 2 21 21
Macromolecular Entities
Polymer Type:polypeptide(L)
Description:PHE-MLU-DLY-SER-DTH-ALA-LEU-LEU
Chain IDs:A, B, C, D, E, F, G, H
Chain Length:8
Number of Molecules:8
Biological Source:Eleftheria
Primary Citation
Structure-Activity Relationship Studies of the Peptide Antibiotic Clovibactin.
J.Org.Chem. 89 12479 12484 (2024)
PMID: 39178334 DOI: 10.1021/acs.joc.4c01414

Abstact

Our laboratory reported the chemical synthesis and stereochemical assignment of the recently discovered peptide antibiotic clovibactin. The current paper reports an improved, gram-scale synthesis of the amino acid building block Fmoc-(2R,3R)-3-hydroxyasparagine-OH that enables structure-activity relationship studies of clovibactin. An alanine scan reveals that residues Phe1, d-Leu2, Ser4, Leu7, and Leu8 are important for antibiotic activity. The side-chain amide group of the rare d-Hyn5 residue is not essential to activity and can be replaced with a methyl group with a moderate loss of activity. An acyclic clovibactin analogue reveals that the macrolactone ring is essential to antibiotic activity. The enantiomer of clovibactin is active, albeit somewhat less so than clovibactin. A conformationally constrained clovibactin analogue retains moderate antibiotic activity, while a backbone N-methylated analogue is almost completely inactive. X-ray crystallography of these two analogues reveals that the macrolactone ring adopts a crown-like conformation that binds anions.

Legend

Protein

Chemical

Disease

Primary Citation of related structures